27.01.2020 13:22:29
|
Sorrento Board Rejects Acquisition Proposal - Quick Facts
(RTTNews) - Sorrento Therapeutics, Inc. (SRNE) said its Board has unanimously rejected the acquisition proposal from a private equity fund as the offer significantly undervalues Sorrento. The non-binding proposal received on January 9, 2020 was valued up to $7.00 per share.
In November 2019, Sorrento rejected term sheet proposal submitted by two biopharmaceutical companies, to acquire all of the issued and outstanding shares of the company for between $3.00 and $5.00 per share in cash.
Sorrento said its management continues to execute on the core drug development and to pursue multiple potential strategic alliances and transactions.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Sorrento Therapeutics Incmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Sorrento Therapeutics Incmehr Analysen
Aktien in diesem Artikel
Sorrento Therapeutics Inc | 0,00 | 0,00% |
|